Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study

Ahmet Özen, Voranush Chongsrisawat, Asena Pınar Sefer, Burcu Kolukısa, Jessica J. Jalbert, Karoline A. Meagher, Taylor Brackin, Hagit Baris Feldman, Elif Karakoç-Aydıner, Rabia Ergelen,

The Lancet · 2024 · 28 citations · 18 references

DOIFull text

Open access

Concepts

References

18